In this issue:
Excess non-TC mortality in survivors of TC cancer
Self-reported QoL as a predictor of mortality in RCC
Outcomes of men with HIV-GCC not inferior to men with HIV-negative GCC
Vinflunine elicits a meaningful clinical response in inoperable penile cancer
Pembrolizumab effective for chemoresistant UC regardless of age
Should FGFR3-mutated MIBC be treated with perioperative pembrolizumab?
PURE-02: Neoadjuvant pembrolizumab not feasible for high-risk UTUC
Blood flow change in metastases after treatment prognostic for survival in RCC
Recovery of health-related QoL after radical cystectomy with intracorporeal diversion
Lenvatinib/everolimus effective in ≥ second-line setting for metastatic RCC
Please login below to download this issue (PDF)